Korro Bio (KRRO) Assets (2018 - 2026)
Korro Bio (KRRO) reported Assets of $163.45 million for Q2 2026, down 9.4% from $180.43 million a year earlier and down 11.0% from the prior quarter.
Powered by 
Analysis
Korro Bio (KRRO) Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Korro Bio posted Assets of $113.51 million, down 49.8% from FY2024.
- Assets has a five-year compound annual growth rate of -15.6% (FY2020 to FY2025).
- By year, Assets came in at $226.24 million in FY2024 (+2.1%), $221.66 million in FY2023 (+200.6%), $73.74 million in FY2022 (-60.2%) and $185.36 million in FY2021 (-30.0%).
- Five-year quarterly Assets spans a low of $46.35 million in Q3 2023 and a high of $249.59 million in Q2 2024.
- Year over year, Assets has now declined in each of the last five quarters, with growth averaging 37.5% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q3 2024 (growth of 425.5%); the low point was Q3 2023 (a decline of 65.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $183.62 million (Q1 2026), $113.51 million (Q4 2025) and $161.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Korro Bio | 145.73 Mn | -250.91 Mn | - | 163.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 163.45 Mn |
| Mar 31, 2026 | 183.62 Mn |
| Dec 31, 2025 | 113.51 Mn |
| Sep 30, 2025 | 161.55 Mn |
| Jun 30, 2025 | 180.43 Mn |
| Mar 31, 2025 | 202.21 Mn |
| Dec 31, 2024 | 226.24 Mn |
| Sep 30, 2024 | 243.54 Mn |
| Jun 30, 2024 | 249.59 Mn |
| Mar 31, 2024 | 197.99 Mn |
| Dec 31, 2023 | 221.66 Mn |
| Sep 30, 2023 | 46.35 Mn |
| Jun 30, 2023 | 79.38 Mn |
| Mar 31, 2023 | 101.50 Mn |
| Dec 31, 2022 | 73.74 Mn |
| Sep 30, 2022 | 136.01 Mn |
| Jun 30, 2022 | 149.66 Mn |
| Mar 31, 2022 | 164.94 Mn |
| Dec 31, 2021 | 185.36 Mn |
| Sep 30, 2021 | 202.19 Mn |
API Access
Korro Bio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=KRRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();